Cleared Traditional

K153584 - NeoTract UroLift System UL500 (FDA 510(k) Clearance)

Mar 2016
Decision
91d
Days
Class 2
Risk

K153584 is an FDA 510(k) clearance for the NeoTract UroLift System UL500. This device is classified as a Implantable Transprostatic Tissue Retractor System (Class II - Special Controls, product code PEW).

Submitted by Neotract, Inc. (Pleasanton, US). The FDA issued a Cleared decision on March 15, 2016, 91 days after receiving the submission on December 15, 2015.

This device falls under the Gastroenterology & Urology FDA review panel. Regulated under 21 CFR 876.5530. The Treatment Of Symptoms Due To Urinary Outflow Obstruction Secondary To Benign Prostatic Hyperplasia (bph) In Men Age 50 And Above..

Submission Details

510(k) Number K153584 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 15, 2015
Decision Date March 15, 2016
Days to Decision 91 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF

Device Classification

Product Code PEW - Implantable Transprostatic Tissue Retractor System
Device Class Class II - Special Controls
CFR Regulation 21 CFR 876.5530
Definition The Treatment Of Symptoms Due To Urinary Outflow Obstruction Secondary To Benign Prostatic Hyperplasia (bph) In Men Age 50 And Above.